(Hillsboro, OR) -- Genentech has broken ground on a 750-million-dollar expansion of its Hillsboro advanced manufacturing facility. It'll create approximately 250 high-wage manufacturing jobs and 200 construction jobs over the duration of the project. The facility is designed to manufacture a broad range of medicines across oncology, neurology, and immunology. Operations are expected to begin in 2031.